Emergent BioSolutions Inc...

5.74
0.02 (0.35%)
At close: Mar 24, 2025, 3:59 PM
5.74
0.04%
After-hours: Mar 24, 2025, 07:55 PM EDT

Emergent BioSolutions Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10 FY09 FY08 FY07 FY06 FY05 FY04 FY01
Net Income -190.6M -760.5M -223.8M 230.9M 305.1M 54.5M 62.7M 82.59M 51.78M 62.87M 36.74M 30.26M 18.14M 16.11M 47.18M 26.55M 20.68M 22.94M 22.79M 15.78M 11.47M 230.9M
Depreciation & Amortization 108.8M 125.1M 143.3M 123.8M 114.5M 110.7M 62.2M 42.57M 38.23M 35.34M 32.45M 18.96M 11.2M 9.36M 5.99M 5M 4.96M 4.82M 4.71M 3.55M 1.87M 123.8M
Stock-Based Compensation 18M 23.1M 45.1M 42.4M 51.8M 26.7M 23.2M 15.21M 18.48M 15.85M 12.83M 11.24M 11.12M 10.74M 7.06M 5.01M 2.51M n/a 723K n/a n/a 42.4M
Other Working Capital 170.6M -59.9M -48.3M -61.7M 23.2M -31.5M -16M 36.33M 813K 4.96M -2.81M -11.28M 9.28M -12.18M -1.65M -1.25M -12.05M 17.72M 10.29M 10.48M -2.85M 94.7M
Other Non-Cash Items 39.3M 485.2M 19.8M 33.5M 59M 37.6M 4.2M 10.78M -14.73M -7.15M 261K -1.49M 8.64M 4.68M 6.51M 12.75M -1.47M -3.46M -285K -17K 491K -28.2M
Deferred Income Tax -5.5M -8.9M -19M 46.9M -2.4M -1.6M 8.6M 3.26M 5.19M 3.46M 16.49M 13.86M 3.38M 20.19M 10.93M 7.6M 2.01M 5.59M 987K -10.97M -418K 46.9M
Change in Working Capital 88.7M -70.3M 500K -156.4M 8.8M -39.9M -119.1M 53.72M -45.45M -65.9M 13.54M 24.14M -12.83M -46.48M 21.87M -26.4M -21.37M 25.54M -32.99M 7.29M -4.46M -94.7M
Operating Cash Flow 58.7M -206.3M -34.1M 321.1M 536M 188M 41.8M 208.14M 53.49M 44.46M 112.32M 96.97M 39.64M 14.59M 99.54M 30.51M 7.32M 55.45M -4.06M 42.25M 9.2M 321.1M
Capital Expenditures -22.9M -51.6M -115.8M -225M -141M -86.9M -72.1M -54.83M -76.26M -44.81M -30.67M -42.02M -53.84M -54.03M -22.1M -33.29M -20.81M -43.97M -41.23M -6.53M -17.07M -225M
Acquisitions n/a 270.2M n/a n/a n/a n/a -827.7M -195.1M n/a -650K -179.38M -25.87M n/a n/a -17.87M n/a n/a n/a -218K -559K n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -4.19M -16.52M n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.97M 4.25M 16.52M n/a n/a n/a n/a n/a 147K n/a
Other Investing Acitivies 148.1M -6.3M -265.5M n/a -10M -10M 2.6M -195.1M n/a n/a n/a -67.89M 11.77M n/a 16.52M n/a -10M -43.97M -192K 1.25M -1.25M n/a
Investing Cash Flow 125.2M 212.3M -381.3M -225M -151M -96.9M -897.2M -249.93M -76.26M -45.46M -210.05M -67.89M -40.11M -53.96M -23.46M -33.29M -30.81M -43.97M -41.64M -5.84M -18.18M -225M
Debt Repayment -198.4M -543.4M 564.2M -35.9M 62.9M 13.7M 795.2M -20M n/a 2M 180.59M -774K 3.32M 12.03M -18.29M 8.54M -751K 15.03M 30.86M -956K 11.76M n/a
Common Stock Repurchased n/a n/a -82.1M -106M -13.8M -7.4M -100K -33.1M -1.1M -100K -200K -213K -5.91M n/a 61.2M n/a n/a n/a -192K -337K -665K -106M
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -5.4M n/a n/a
Other Financial Acitivies -900K -700K -900K 900K 6.6M -49.6M -6.4M 1.7M -18.64M 31.55M 18.49M 9.6M 821K 2.22M 1.7M 1.84M 6.33M 995K 532K n/a -2.42M -141M
Financial Cash Flow -190M -535.7M 481.2M -141M 69.5M -35.9M 788.7M -51.4M -18.64M 33.45M 198.87M 8.61M -1.76M 14.25M -9.36M 14.84M 8.97M 18.49M 86.02M -6.66M 8.68M -141M
Net Cash Flow -6.1M -530.9M 66.3M -45.2M 453.5M 55.6M -66.9M -93.22M -41.28M 32.3M 101.16M 37.67M -2.23M -25.12M 66.09M 11.45M -14.26M 29.31M 40.12M 29.47M -298K -45.2M
Free Cash Flow 35.8M -257.9M -149.9M 96.1M 395M 101.1M -30.3M 153.31M -22.77M -353K 81.64M 54.95M -14.2M -39.43M 77.44M -2.78M -13.5M 11.48M -45.29M 35.72M -7.88M 96.1M